These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. The use of a vacuum-assisted biopsy device (Mammotome) in the early detection of breast cancer in the United Arab Emirates. Faour I, Al-Salam S, El-Terifi H, El Taji H. Ann N Y Acad Sci; 2008 Sep; 1138():108-13. PubMed ID: 18837890 [Abstract] [Full Text] [Related]
9. Vacuum-assisted stereotactic breast biopsy: histologic underestimation of malignant lesions. Burak WE, Owens KE, Tighe MB, Kemp L, Dinges SA, Hitchcock CL, Olsen J. Arch Surg; 2000 Jun; 135(6):700-3. PubMed ID: 10843367 [Abstract] [Full Text] [Related]
10. Underestimation of the presence of breast carcinoma in papillary lesions initially diagnosed at core-needle biopsy. Sydnor MK, Wilson JD, Hijaz TA, Massey HD, Shaw de Paredes ES. Radiology; 2007 Jan; 242(1):58-62. PubMed ID: 17090707 [Abstract] [Full Text] [Related]
11. Lobular neoplasia at 11-gauge vacuum-assisted stereotactic biopsy: correlation with surgical excisional biopsy and mammographic follow-up. Mahoney MC, Robinson-Smith TM, Shaughnessy EA. AJR Am J Roentgenol; 2006 Oct; 187(4):949-54. PubMed ID: 16985141 [Abstract] [Full Text] [Related]
12. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions. Burns RP, Brown JP, Roe SM, Sprouse LR, Yancey AE, Witherspoon LE. Ann Surg; 2000 Oct; 232(4):542-8. PubMed ID: 10998652 [Abstract] [Full Text] [Related]